doi: 10.1002/lary.32061 67
Hormonal and metabolic changes after pregnancy Hormones shift quickly after delivery
Rhode Islands governor has also proposed ending coverage of the drugs
[25] Cancer [edit] In response to a report of precancerous changes in the pancreases of rats and organ donors treated with the DPP-4 inhibitor sitagliptin, [26] [27] the US FDA and the European Medicines Agency each undertook independent reviews of all clinical and preclinical data related to the possible association of DPP-4 inhibitors with pancreatic cancer
Potential for Broader Indications Given that obesity is linked with numerous comorbidities, CT-388 could have a range of potential future indications beyond obesity and T2D, such as nonalcoholic steatohepatitis (NASH), cardiovascular diseases (CVD), heart failure, osteoarthritis, sleep apnea, and chronic kidney disease (CKD)
Intra-myocardial delivery of a novel thermosensitive hydrogel inhibits post-infarct heart failure after degradation in rat